Operating Lease, Right-of-Use Asset of ANAPTYSBIO, INC from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ANAPTYSBIO, INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
  • ANAPTYSBIO, INC Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $12,994,000, a 12% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

ANAPTYSBIO, INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $12,994,000 -$1,845,000 -12% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $13,464,000 -$1,827,000 -12% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $13,923,000 -$1,809,000 -11% 31 Mar 2025 10-Q 05 May 2025 2025 Q1
Q4 2024 $14,383,000 -$1,791,000 -11% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $14,839,000 -$1,774,000 -11% 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 $15,291,000 -$1,756,000 -10% 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 $15,732,000 -$1,739,000 -10% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $16,174,000 -$1,724,000 -9.6% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $16,613,000 -$1,707,000 -9.3% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $17,047,000 -$1,692,000 -9% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $17,471,000 -$1,676,000 -8.8% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $17,898,000 -$1,660,000 -8.5% 31 Dec 2022 10-K 11 Mar 2024 2023 FY
Q3 2022 $18,320,000 -$1,458,000 -7.4% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $18,739,000 -$1,539,000 -7.6% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $19,147,000 +$18,929,000 +8683% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $19,558,000 +$19,214,000 +5585% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $19,778,000 +$18,954,000 +2300% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $20,278,000 +$19,258,000 +1888% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $218,000 -$995,000 -82% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $344,000 -$1,058,000 -75% 31 Dec 2020 10-K 07 Mar 2022 2021 FY
Q3 2020 $824,000 -$762,000 -48% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 $1,020,000 -$744,000 -42% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $1,213,000 -$727,000 -37% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $1,402,000 -$698,000 -33% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $1,586,000 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $1,764,000 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $1,940,000 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $2,100,000 01 Jan 2019 10-K 25 Feb 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.